But these changes may also feel restrictive and overwhelming
Finally, to address potential pleiotropic effects, we excluded SNPs associated with other potential confounders identified through PhenoScanner ( Outcome sources To minimize potential bias due to population diversity, we restricted our drug target MR analysis to participants of European ancestry

Besides the results from preclinical models of breast cancer shows that blocking the cancer's ability to use glutathione slowed down tumor growth Further making use of an advanced technology to search for therapies that could inhibit a tumor's ability to use glutathione, the team identified pharmacological targeting of the activity of -glutamyltransferases (GGT) using GGsTop, a putative inhibitor of GGT activity prevents the breakdown of circulating GSH leading to reduced tumour cysteine levels and slowed tumour growth In a nutshell, the findings indicate a non-canonical role for GSH in supporting tumours by acting as a reservoir of amino acids and that depriving tumours of extracellular GSH or inhibiting its breakdown could potentially prove to be a therapeutically tractable approach for patients with cancer Hecht, F., Zocchi, M., Tuttle, E.T
Short answer: GLP-1 medications can be used short term, but they are generally designed for ongoing weight management